Vertex Pharmaceuticals
VRTX
#146
Rank
A$201.23 B
Marketcap
A$793.72
Share price
0.85%
Change (1 day)
22.45%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2023 (TTM): A$19.72

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$25.14. In 2022 the company made an earnings per share (EPS) of A$18.83 an increase over its 2021 EPS that were of A$13.20.

EPS history for Vertex Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$19.724.72%
2022A$18.8342.64%
2021A$13.20-12.67%
2020A$15.12128.01%
2019A$6.63-44.54%
2018A$11.95670.09%
2017A$1.55-327.66%
2016A-$0.68-79.65%
2015A-$3.35-26.43%
2014A-$4.5653.92%
2013A-$2.96316.33%
2012A-$0.71-545.45%
2011A$0.16-102.92%
2010A-$5.471.34%
2009A-$5.4013.41%
2008A-$4.768.61%
2007A-$4.3864.13%
2006A-$2.67-18.22%
2005A-$3.266.13%
2004A-$3.08-16.86%
2003A-$3.7078.32%
2002A-$2.07164.81%
2001A-$0.78-21.32%
2000A-$1.00-14.21%
1999A-$1.1621.21%
1998A-$0.9657.14%
1997A-$0.61-61.82%
1996A-$1.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.70-61.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.18-79.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.50-117.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.44-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.56-73.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A-$3.50-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA